Forward Citations = 5

Loading Chart...

12 inventors (with patents filed for the assignee):

Nancy Yuk-Yu Ip (3 out of 13 patents)

Fanny Chui-Fun Ip (2 out of 6 patents)

Yueqing Hu (2 out of 5 patents)

4. Kit Yu Fu (1 out of 9 patents)

5. Fanny Chui Fun Ip (1 out of 5 patents)

6. Yifan Han (1 out of 2 patents)

7. Shengjun Guo (1 out of 1 patent)

8. Zhenguo Wu (1 out of 1 patent)

9. Jerry Hsueh-Ching Wang (1 out of 1 patent)

10. Jun Wan (1 out of 1 patent)

11. Nancy Y Ip (1 out of 4 patents)

12. Sookja Kim Chung (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 9150608 - Neuro-protective compounds and their use (2015-10-06),

2. 9134327 - STAT3 and TYK2 as drug targets for neurodegenerative diseases (2015-09-15),

3. 9029414 - Triterpenoid compounds and methods of use thereof (2015-05-12),

4. 7605265 - Heterodimers and methods of using them (2009-10-20),

Company Overview

Biotechnology Research Corporation Limited is a leading biotech company specialized in genetic research, drug development, and molecular diagnostics. With a team of experienced scientists and cutting-edge facilities, we are committed to advancing healthcare through innovative biotechnology solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#737 in Hong Kong

#6,438 in China

Hong Kong, China

Biotechnology Research Corporation Limited

Forward Citations = 5

12 inventors:

Nancy Yuk-Yu Ip (3 out of 13 patents)

Fanny Chui-Fun Ip (2 out of 6 patents)

Yueqing Hu (2 out of 5 patents)

4. Kit Yu Fu (1 out of 9 patents)

5. Fanny Chui Fun Ip (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biotechnology Research Corporation Limited. Retrieved from https://idiyas.com/company/biotechnology-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]